Gitogenin impedes tumorigenesis in hepatocellular carcinoma via NUAK2/NF-κB axis - Top-Institutions - MDSpire

Gitogenin impedes tumorigenesis in hepatocellular carcinoma via NUAK2/NF-κB axis

  • By

  • Xiaomei Bao

  • Yiman Liu

  • Hua Sheng

  • Qingge Dai

  • Lingjuan Sun

  • Ye Zhang

  • Yuehong Ma

  • Yu Dong

  • June 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Type Culture Collection of Chinese Academy of Sciences
    Type Culture Collection of Chinese Academy of Sciences

    Shanghai, China

    Key Differentiators

    • Oncology

  • #2

    Shanghai Cancer Institute & Department of Renji Hospital
    Shanghai Cancer Institute & Department of Renji Hospital

    Shanghai, China

    Key Differentiators

    • Oncology

  • #3

    Oregon Health & Science University
    Oregon Health & Science University

    Portland, Oregon

    Key Differentiators

    • Oncology

Original Source(s)

Gitogenin impedes tumorigenesis in hepatocellular carcinoma via NUAK2/NF-κB axis

  • by Xiaomei Bao, Yiman Liu, Hua Sheng, Qingge Dai, Lingjuan Sun, Ye Zhang, Yuehong Ma, Yu Dong

  • June 24, 2026

Related Content

Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study

Engineered exosomes deliver structurally optimized toad BAX to reactivate mitochondrial apoptosis in colorectal cancer

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients